GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » Cyclically Adjusted Price-to-FCF

Indivior (LSE:INDV) Cyclically Adjusted Price-to-FCF : 13.98 (As of May. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Cyclically Adjusted Price-to-FCF?

As of today (2024-05-22), Indivior's current share price is £13.28. Indivior's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was £0.95. Indivior's Cyclically Adjusted Price-to-FCF for today is 13.98.

The historical rank and industry rank for Indivior's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

LSE:INDV' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 9.4   Med: 13.9   Max: 17.84
Current: 14.03

During the past years, Indivior's highest Cyclically Adjusted Price-to-FCF was 17.84. The lowest was 9.40. And the median was 13.90.

LSE:INDV's Cyclically Adjusted Price-to-FCF is ranked better than
82.01% of 328 companies
in the Drug Manufacturers industry
Industry Median: 33.51 vs LSE:INDV: 14.03

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Indivior's adjusted free cash flow per share data for the three months ended in Mar. 2024 was £-0.323. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is £0.95 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Indivior Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Indivior's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Cyclically Adjusted Price-to-FCF Chart

Indivior Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 11.79

Indivior Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.95 14.79 14.73 11.79 17.84

Competitive Comparison of Indivior's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Indivior's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indivior's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indivior's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Indivior's Cyclically Adjusted Price-to-FCF falls into.



Indivior Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Indivior's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=13.28/0.95
=13.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Indivior's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.323/131.7762*131.7762
=-0.323

Current CPI (Mar. 2024) = 131.7762.

Indivior Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.882 100.560 1.156
201409 0.515 100.428 0.676
201412 0.116 99.070 0.154
201503 0.762 99.621 1.008
201506 0.241 100.684 0.315
201509 0.240 100.392 0.315
201512 0.210 99.792 0.277
201603 0.446 100.470 0.585
201606 0.364 101.688 0.472
201609 0.445 101.861 0.576
201612 0.620 101.863 0.802
201703 0.281 102.862 0.360
201706 0.610 103.349 0.778
201709 0.130 104.136 0.165
201712 0.284 104.011 0.360
201803 0.086 105.290 0.108
201806 0.286 106.317 0.354
201809 0.525 106.507 0.650
201812 0.440 105.998 0.547
201903 0.667 107.251 0.820
201906 -0.329 108.070 -0.401
201909 0.203 108.329 0.247
201912 0.183 108.420 0.222
202003 -0.759 108.902 -0.918
202006 -0.010 108.767 -0.012
202009 0.130 109.815 0.156
202012 -0.347 109.897 -0.416
202103 0.411 111.754 0.485
202106 0.324 114.631 0.372
202109 0.631 115.734 0.718
202112 0.894 117.630 1.002
202203 -0.389 121.301 -0.423
202206 0.149 125.017 0.157
202209 0.373 125.227 0.393
202212 -0.109 125.222 -0.115
202303 -0.245 127.348 -0.254
202306 -0.111 128.729 -0.114
202309 -0.039 129.860 -0.040
202312 -1.685 129.419 -1.716
202403 -0.323 131.776 -0.323

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Indivior  (LSE:INDV) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Indivior Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Indivior's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Indivior (LSE:INDV) Business Description

Industry
Traded in Other Exchanges
Address
234 Bath Road, Slough, Berkshire, GBR, SL1 4EE
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.